Fig. 2From: Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancerSurvival curves in patients with stage III/IV (n = 150) or I/II (n = 130) disease according to the presence/absence of pretreatment thrombocytosis. a, PFS in stage III/IV patients. b, OS in stage III/IV patients. c, PFS in stage I/II patients. D, OS in stage I/II patientsBack to article page